Research & Development

The research behind Alertix

Alertix’ assays are developed by a research team at The Swedish University of Agricultural Sciences (SLU) lead by Professor Staffan Eriksson.

The research is focused on deoxynucleotide, which are the building blocks of DNA, and especially on the enzyme thymidine kinase (TK1) as a biomarker of cancer diseases. It is previously known that TK1 is released into the bloodstream in case of tumor growth. There is also evidence that this can happen even in case of pre-cancerous conditions.

A scientific breakthrough occurred when Staffan Eriksson’s team developed an immunochemical method for measuring TK1 in the blood. The method offer great benefits compared to previously established methods for determining TK1. It is unique and patented in EU/USA/CAN/AUS/JPN.

Alertix Canine - for Dogs

Cancer test for early detection in dogs, available as home test, or at selected veterinary clinics and labs in Sweden

Alertix Feline - for Cats

Test for early detection, monitoring and screening of tumor diseases in cats. Under development, expected late 2024.

Alertix Equine - for Horses

Test for early detection, monitoring and screening of tumor diseases in horses. Under development, expected late 2024.